B U Sevin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B U Sevin

Showing results (111-120 of 136) with videos related to

Pageof 14

Sort By:

Gynecologic Oncology|April 1, 1994

Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.

Gynecologic Oncology|June 1, 1980

Fine-needle-aspiration cytology in gynecologic oncology: "early detection of occult persistent or recurrent cancer after radiation therapy"B U Sevin, M Nadji, S E Greening, et al.

Oncology|November 1, 1994

Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.

American Journal of Surgery|May 31, 1988

Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomyA S Berkeley, J W Orr, D Cavanagh, et al.

Biotherapy (Dordrecht, Netherlands)|January 1, 1997

Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophagesP G Braunschweiger, V S Basrur, D Cameron, et al.

Gynecologic Oncology|November 1, 1992

Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.

Obstetrics and Gynecology|April 1, 1979

Invasive cancer of the cervix after cryosurgery. Pitfalls of conservative managementB U Sevin, J H Ford, R D Girtanner, et al.

Gynecologic Oncology|July 1, 1993

The role of DNA index as a prognostic factor in early cervical carcinomaH N Nguyen, B U Sevin, H E Averette, et al.

Gynecologic Oncology|September 1, 1993

Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomyT A Harrison, B U Sevin, O Koechli, et al.

Gynecologic Oncology|July 1, 1992

Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometryH N Nguyen, B U Sevin, H E Averette, et al.

Pageof 14

Search research articles

Showing results (111-120 of 136) with videos related to

Sort By:

Pageof 14

Gynecologic Oncology|April 1, 1994

Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.

Gynecologic Oncology|June 1, 1980

Fine-needle-aspiration cytology in gynecologic oncology: "early detection of occult persistent or recurrent cancer after radiation therapy"B U Sevin, M Nadji, S E Greening, et al.

Oncology|November 1, 1994

Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.

American Journal of Surgery|May 31, 1988

Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomyA S Berkeley, J W Orr, D Cavanagh, et al.

Biotherapy (Dordrecht, Netherlands)|January 1, 1997

Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophagesP G Braunschweiger, V S Basrur, D Cameron, et al.

Gynecologic Oncology|November 1, 1992

Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitroM Untch, B U Sevin, J P Perras, et al.

Obstetrics and Gynecology|April 1, 1979

Invasive cancer of the cervix after cryosurgery. Pitfalls of conservative managementB U Sevin, J H Ford, R D Girtanner, et al.

Gynecologic Oncology|July 1, 1993

The role of DNA index as a prognostic factor in early cervical carcinomaH N Nguyen, B U Sevin, H E Averette, et al.

Gynecologic Oncology|September 1, 1993

Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomyT A Harrison, B U Sevin, O Koechli, et al.

Gynecologic Oncology|July 1, 1992

Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometryH N Nguyen, B U Sevin, H E Averette, et al.

Pageof 14